Invesco’s AbbVie ABBV Stock Holding History

Invesco’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,800	Closed	-$1.88M	–	3646
2019 Q3	$1.88M	Hold	24,800	–	–	﹤0.01%	2674
2019 Q2	$1.8M	Hold	24,800	–	–	﹤0.01%	2758
2019 Q1	$2M	Buy	24,800 +8,300	+50%	+$679K	﹤0.01%	2610
2018 Q4	$1.52M	Hold	16,500	–	–	﹤0.01%	2726
2018 Q3	$1.56M	Buy	+16,500	New	+$1.56M	﹤0.01%	2924
2017 Q1	–	Sell	-600	Closed	-$38K	–	3692
2016 Q4	$38K	Hold	600	–	–	﹤0.01%	3670
2016 Q3	$38K	Hold	600	–	–	﹤0.01%	3646
2016 Q2	$37K	Hold	600	–	–	﹤0.01%	3671
2016 Q1	$34K	Hold	600	–	–	﹤0.01%	3684
2015 Q4	$36K	Hold	600	–	–	﹤0.01%	3719
2015 Q3	$33K	Buy	+600	New	+$39.1K	﹤0.01%	3763

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco's ABBV Position: Q2 2026 in Review

Invesco reduced its AbbVie (ABBV) stake by 8.8% in Q2 2026, selling an estimated $147M and leaving 7,114,782 shares worth $1.79B. The position accounts for 0.14% of the portfolio, ranked #113.

Invesco first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.85B in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Invesco held 7,114,782 shares of AbbVie worth $1.79B as of Q2 2026.
Invesco sold 683,266 AbbVie shares in Q2 2026, an estimated $147M.
AbbVie made up 0.14% of Invesco's portfolio in Q2 2026, its #113 holding.
Invesco first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Invesco's AbbVie position peaked at $1.85B in Q4 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.